Last reviewed · How we verify
NCT07110051
Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
NA trial testing Nalbuphine in Tramadol in 128 participants. Currently enrolling.
15 September 2025
Quick facts
| Lead sponsor | National Cancer Institute, Egypt |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 128 |
| Start date | 15 January 2025 |
| Primary completion | 15 September 2025 |
| Estimated completion | 15 October 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Nalbuphine — full drug profile →
- Tramadol (tramadol) — full drug profile →
Conditions studied
- Tramadol — all drugs for Tramadol →
- Nalbuphine — all drugs for Nalbuphine →
- Abdominal Surgeries — all drugs for Abdominal Surgeries →
- Pediatric Cancer — all drugs for Pediatric Cancer →
Sponsor
National Cancer Institute, Egypt
Who can join
Adults 3 to 12, any sex, with Tramadol or Nalbuphine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparative Study between Nalbuphine versus Tramadol on Postoperative Analgesia for Abdominal Surgery in Pediatric Cancer Patients: A Prospective, Randomized Clinical Trial
Elshamy FHMM, Ahmed AF, Zayed NOA, Gamal RM. · · 2025 · DOI 10.21203/rs.3.rs-7805933/v1
Verify or expand the search:
- PubMed search for NCT07110051
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nalbuphine
Trials testing the same drug.
- NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
- NCT07422558 — Intravenous Nalbuphine Versus Lidocaine for Prevention of Propofol Injection Pain · NA · not yet recruiting
- NCT07435337 — Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy · Phase 4 · recruiting
- NCT07269106 — Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery · Phase 4 · recruiting
- NCT07279727 — Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb · Phase 1 · not yet recruiting
Other recruiting trials for Tramadol
Currently open trials in the same condition.
- NCT06742554 — Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulder Arthrosc · Phase 4 · active not recruiting
Other National Cancer Institute, Egypt trials
Trials by the same sponsor.
- NCT07424638 — Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain · NA · recruiting
- NCT07367568 — Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy · NA · recruiting
- NCT07367581 — Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer · NA · recruiting
- NCT07337330 — Ultrasound Guided External Oblique Intercostal Plane Block Versus Erector Spinae Block for Post Hepatectomy Pain · NA · not yet recruiting
- NCT07390448 — Rhomboid Intercostal Sub-serratus Plane Blocks and Erector Spinae Plane Block in Mastectomy Surgeries · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07110051 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Institute, Egypt
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07110051.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing